| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
868,994 |
|
|
Indirect Shares
|
241,951 |
|
|
| Direct
Value |
$900,729,661 |
|
|
|
Indirect Value
|
$250,787,051 |
|
|
| Total
Shares |
1,110,945 |
|
|
| Total
Value |
$1,151,516,711 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-06-10 |
868,994 |
2024-06-10 |
241,951 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
147 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
D |
$476.42 |
$61,420,543 |
D/D |
(128,921) |
635,614 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
OE |
$7.41 |
$741,000 |
D/D |
100,000 |
636,103 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
D |
$385.08 |
$40,885,484 |
D/D |
(106,174) |
680,612 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-10-30 |
4 |
OE |
$11.64 |
$2,128,002 |
D/D |
182,818 |
682,818 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2009-12-03 |
4 |
OE |
$8.77 |
$877,000 |
D/D |
100,000 |
688,235 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
OE |
$20.32 |
$3,964,005 |
D/D |
195,079 |
697,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-09 |
4 |
OE |
$30.63 |
$7,557,524 |
D/D |
246,736 |
713,990 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
752,486 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2019-02-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,722 |
753,316 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2023-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,155 |
765,327 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-05-16 |
4 |
AS |
$967.40 |
$48,636,545 |
D/D |
(50,000) |
786,383 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
OE |
$21.92 |
$4,284,001 |
D/D |
195,438 |
786,786 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
D |
$953.83 |
$117,894,342 |
D/D |
(123,601) |
801,608 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
D |
$483.25 |
$104,773,433 |
D/D |
(216,810) |
822,207 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO & Pres, REGN Res Labs |
• • – |
2012-01-05 |
4 |
AS |
$58.00 |
$1,607,354 |
D/D |
(27,713) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-05-01 |
4 |
AS |
$133.95 |
$4,471,669 |
D/D |
(33,165) |
833,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-05-15 |
4 |
AS |
$965.69 |
$48,793,727 |
D/D |
(50,000) |
836,383 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-12-14 |
4 |
D |
$51.18 |
$1,971,249 |
D/D |
(38,516) |
860,754 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-03-26 |
4 |
AS |
$120.21 |
$3,985,850 |
D/D |
(33,150) |
866,206 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
870,375 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-08-16 |
4 |
AS |
$625.25 |
$30,781,138 |
D/D |
(49,227) |
887,483 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2011-12-01 |
4 |
AS |
$58.86 |
$1,645,591 |
D/D |
(27,713) |
899,270 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-02-15 |
4 |
D |
$109.29 |
$7,324,288 |
D/D |
(67,017) |
899,356 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2012-02-15 |
4 |
OE |
$8.50 |
$1,133,322 |
D/D |
133,332 |
901,079 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-12-30 |
4 |
OE |
$52.03 |
$20,712,050 |
D/D |
398,079 |
908,303 |
0 |
- |
|
147 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
